Published in Br J Cancer on February 27, 2006
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer (2009) 2.01
Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer (2010) 1.67
Correlation of global and gene-specific DNA methylation in maternal-infant pairs. PLoS One (2010) 1.40
Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics (2011) 1.29
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res (2006) 1.25
Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol (2007) 1.13
Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen (2012) 1.09
Analysis of splicing patterns by pyrosequencing. Nucleic Acids Res (2009) 1.04
Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn (2010) 1.03
The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer (2013) 1.01
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol (2010) 0.98
Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas. Br J Cancer (2008) 0.95
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer (2009) 0.95
p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review. Dis Markers (2014) 0.94
Role of DNA methylation in head and neck cancer. Clin Epigenetics (2011) 0.94
Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg (2011) 0.91
Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics (2008) 0.91
Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics (2010) 0.90
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer (2009) 0.89
DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Int J Med Sci (2013) 0.88
Genome-wide assays that identify and quantify modified cytosines in human disease studies. Epigenetics Chromatin (2015) 0.88
Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene. Mol Ther (2012) 0.87
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. BMC Cancer (2015) 0.86
Delineating an epigenetic continuum in head and neck cancer. Cancer Lett (2012) 0.84
Epigenetic mechanisms in oral carcinogenesis. Future Oncol (2012) 0.83
Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes. Epigenetics (2015) 0.83
Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol (2012) 0.83
Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies. PLoS One (2015) 0.81
DNA methylotype analysis in colorectal cancer. Oncol Rep (2008) 0.80
Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma. J Cell Physiol (2014) 0.79
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma. Br J Cancer (2010) 0.79
Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma. Biomed Res Int (2014) 0.79
Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes. Oral Oncol (2006) 0.79
Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence. BMC Cancer (2014) 0.79
SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma. Br J Cancer (2014) 0.79
Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. PLoS One (2015) 0.78
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. Br J Cancer (2013) 0.78
Constitutional promoter methylation and risk of familial melanoma. Epigenetics (2014) 0.78
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome. Clin Epigenetics (2014) 0.78
Histone modifications: Targeting head and neck cancer stem cells. World J Stem Cells (2014) 0.78
Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med (2016) 0.78
Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin. Tumour Biol (2014) 0.77
Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor. World J Gastroenterol (2010) 0.77
Promoter methylation in head and neck tumorigenesis. Methods Mol Biol (2012) 0.77
Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing. Tuberc Respir Dis (Seoul) (2012) 0.77
Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer. Exp Ther Med (2012) 0.77
Methylation-mediated molecular dysregulation in clinical oral malignancy. J Oncol (2012) 0.76
Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients. PLoS One (2015) 0.76
Interactions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplay. Biomed Res Int (2014) 0.76
Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells. Int J Mol Sci (2015) 0.76
The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies. Onco Targets Ther (2016) 0.75
Predictive value of epigenetic alterations in head and neck squamous cell carcinoma. Mol Cell Oncol (2014) 0.75
Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested. Oncotarget (2016) 0.75
DNA methylation induced epigenetic silencing: a potential biomarker and therapeutic target for head and neck squamous cell carcinoma. J Int Oral Health (2015) 0.75
Intermediate Tyrosyl Radical and Amyloid Structure in Peroxide-Activated Cytoglobin. PLoS One (2015) 0.75
Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India. Clin Epigenetics (2017) 0.75
Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma. Oncol Lett (2016) 0.75
Modeling DNA methylation by analyzing the individual configurations of single molecules. Epigenetics (2016) 0.75
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A (1992) 29.51
CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13
Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques (2003) 5.49
Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet (1999) 3.26
Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques (2003) 3.05
A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res (1990) 2.81
De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem (2004) 2.73
Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol (2002) 2.53
A ubiquitously expressed human hexacoordinate hemoglobin. J Biol Chem (2002) 2.03
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res (2000) 1.91
Prognostic relevance of molecular markers of oral cancer--a review. Int J Oral Maxillofac Surg (2003) 1.77
Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res (2004) 1.74
Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol (2003) 1.65
Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene (2002) 1.49
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res (2005) 1.38
A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol (2005) 1.35
Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res (2002) 1.33
Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res (2002) 1.33
Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res (2004) 1.27
Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res (2004) 1.27
The epigenetics of oral cancer. Int J Oral Maxillofac Surg (2005) 1.26
Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer (2003) 1.22
Neuroglobin and cytoglobin: genes, proteins and evolution. IUBMB Life (2005) 1.12
The CpG-specific methylase SssI has topoisomerase activity in the presence of Mg2+. Nucleic Acids Res (1994) 1.11
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett (2002) 1.11
Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res (1995) 1.07
Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. Mol Carcinog (2005) 1.07
Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer (2002) 1.06
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res (2004) 1.05
Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep (2004) 1.04
Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol (2004) 1.01
Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene. Hum Genet (2004) 0.96
Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res (2002) 0.95
An investigation of the tylosis with oesophageal cancer (TOC) locus in Iranian patients with oesophageal squamous cell carcinoma. Int J Oncol (2004) 0.94
Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool? Eur J Cancer (2003) 0.93
The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Anticancer Res (2003) 0.91
Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. Cancer Res (1999) 0.91
Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus. Oncogene (2002) 0.89
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene (2003) 0.89
Malignancy grading of squamous cell carcinoma in the floor of the mouth related to clinical evaluation. Scand J Dent Res (1986) 0.88
Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology. FEBS Lett (2001) 0.88
Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol (2003) 0.85
Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol (2000) 0.82
A clinician friendly computerised head and neck oncology audit: the first year results. Ann R Coll Surg Engl (1996) 0.78
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodeling. Cancer Biol Ther (2004) 0.77
Minor operations in general practice. Br Med J (1979) 6.47
Circumstances and consequences of falls experienced by a community population 70 years and over during a prospective study. Age Ageing (1990) 4.55
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
A minor operating list in general practice using an improved method of intravenous regional anaesthesia. Practitioner (1978) 4.08
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) (1982) 3.71
Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol (2001) 3.36
Annual direct cost of urinary incontinence. Obstet Gynecol (2001) 3.35
The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery (1968) 3.21
The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15
Stoichiometry of system I and system II reaction centers and of plastoquinone in different photosynthetic membranes. Proc Natl Acad Sci U S A (1980) 2.83
Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission. Age Ageing (2007) 2.80
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol (1988) 2.63
Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax (2003) 2.63
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer (1989) 2.62
Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer (1995) 2.47
Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax (2010) 2.38
Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol (2004) 2.24
Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax (2002) 2.22
Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol (2001) 2.21
Airborne contamination of wounds in joint replacement operations: the relationship to sepsis rates. J Hosp Infect (1983) 2.20
Vascularized iliac crest with internal oblique muscle for immediate reconstruction after maxillectomy. Br J Oral Maxillofac Surg (2002) 2.20
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol (1992) 2.09
Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet (2004) 2.08
Tumour-associated eosinophilia: a review. J Clin Pathol (1981) 2.03
A practical guide for patients undergoing exodontia following radiotherapy to the oral cavity. Dent Update (2002) 2.03
A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol (2006) 2.01
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer (2009) 2.01
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther (2013) 2.01
The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond (2000) 1.97
Radial forearm flap donor-site complications and morbidity: a prospective study. Plast Reconstr Surg (1997) 1.96
Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol (1994) 1.96
Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int (2000) 1.93
Characterization of factors that direct transcription of rat ribosomal DNA. Mol Cell Biol (1990) 1.93
Audit of acute admissions of COPD: standards of care and management in the hospital setting. Eur Respir J (2001) 1.90
UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax (2006) 1.89
Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors. J Hyg (Lond) (1984) 1.85
Naturally occurring chlorophyll types and their function in photosynthesis. Biochem Soc Symp (1968) 1.82
Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol (2003) 1.81
Stroke units: research and reality. Results from the National Sentinel Audit of Stroke. Qual Saf Health Care (2005) 1.80
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol (1997) 1.74
Benign and malignant teratomas in children: analysis of 85 patients. Surgery (1976) 1.71
Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ (2006) 1.70
Malignant eccrine poroma: a study of twenty-seven cases. Br J Dermatol (1982) 1.66
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol (1982) 1.64
Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol (1992) 1.63
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
A randomised trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project. Clin Med (2010) 1.62
Isolation and characterization of two sequence-specific endonucleases from Anabaena variabilis. Biochem J (1976) 1.62
National stroke audit: a tool for change? Qual Health Care (2001) 1.61
Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol (2005) 1.55
Regional deposition and retention of particles in shallow, inhaled boluses: effect of lung volume. J Appl Physiol (1985) (1999) 1.51
Assessment of problems with appearance, following surgery for oral and oro-pharyngeal cancer using the University of Washington appearance domain and the Derriford appearance scale. Oral Oncol (2008) 1.51
A modified classification for the maxillectomy defect. Head Neck (2000) 1.51
Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry (2010) 1.49
Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct (2002) 1.49
Changes in practice and organisation surrounding blood transfusion in NHS trusts in England 1995-2005. Qual Saf Health Care (2008) 1.47
Reliability and validity of the Intercollegiate Stroke Audit Package. J Eval Clin Pract (2001) 1.46
Inferior alveolar nerve damage caused by bone wax in third molar surgery. Int J Oral Maxillofac Surg (2010) 1.46
Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol (1993) 1.45
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel (2008) 1.45
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J Urol (1999) 1.44
The influence of hyperbaric oxygen on the outcome of patients treated for osteoradionecrosis: 8 year study. Int J Oral Maxillofac Surg (2007) 1.43
Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol (1993) 1.43
Through the endoscope: a novel method of nasogastric tube insertion during oesophagoscopy. Clin Otolaryngol (2008) 1.42
Comorbidities associated with overactive bladder. Am J Manag Care (2000) 1.41
Survival of a free flap after arterial disconnection at six days. Br J Oral Maxillofac Surg (2004) 1.41
Four universal forms of chlorophyll a. Plant Physiol (1972) 1.41
Major conceptual change required to improve lung cancer: see a respiratory physician. Eur Respir J (2003) 1.40
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid) Ann Allergy (1993) 1.40
Adult respiratory distress syndrome after microvascular free tissue reconstruction in head and neck malignancy. Br J Oral Maxillofac Surg (1998) 1.39
Cervical contractions: the response of the cervix to oxytocic stimulation in the latent phase of labour. Br J Obstet Gynaecol (1993) 1.38
Indirect laryngoscopy - the cold way. Clin Otolaryngol (2007) 1.37
Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax (2001) 1.37
Relinquishing the sick role following open-heart surgery. J Health Soc Behav (1975) 1.34
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med (1992) 1.32
Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol (1999) 1.32